Hercules Capital Board Member DeAnne Aguirre Restructures Stock Holdings Through Trust
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Form 4 filing reveals insider trading activity for DeAnne Aguirre, Director at Hercules Capital (HTGC). On June 18, 2025, Aguirre underwent multiple transactions:
- Acquisition: Received 3,329 shares of restricted stock at $18.02 per share as an automatic grant upon board re-election, subject to three-year vesting schedule (one-third annually)
- Ownership Transfer: 5,999 shares were transferred from direct ownership to indirect ownership through the Aguirre Family 2004 Trust
Following these transactions, Aguirre's holdings include:
- Direct ownership: 5,067 shares (including 45 shares from dividend reinvestment on May 20, 2025)
- Indirect ownership: 18,180 shares held through the family trust
Positive
- Director DeAnne Aguirre received 3,329 shares of restricted stock at $18.02 per share as part of standard board compensation, demonstrating continued alignment with shareholder interests
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Aguirre DeAnne
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,329 | $18.02 | $60K |
| Disposition | Common Stock | 5,999 | $0.00 | -- |
| Grant/Award | Common Stock | 5,999 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 11,021 shares (Direct);
Common Stock — 18,180 shares (Indirect, By Trust)
Footnotes (1)
- Restricted Stock issued as an automatic grant upon re-election to the board of directors pursuant to the 2018 Non-Employee Director Plan and subject to forfeiture restrictions. One-third vests on the anniversary of the grant over three years. Shares previously reported as directly owned are now being reported as indirectly owned. Includes 45 dividend reinvestment shares acquired on May 20, 2025. Held by the Aguirre Family 2004 Trust.
FAQ
What was the price of HTGC restricted stock granted to DeAnne Aguirre in the June 2025 transaction?
The restricted stock was granted at a price of $18.02 per share according to the Form 4 filing.